Pommier Y, Nussenzweig A, Takeda S, Austin C
Nat Rev Mol Cell Biol. 2022; 23(6):407-427.
PMID: 35228717
PMC: 8883456.
DOI: 10.1038/s41580-022-00452-3.
Sciascia N, Wu W, Zong D, Sun Y, Wong N, John S
Elife. 2020; 9.
PMID: 32057297
PMC: 7089766.
DOI: 10.7554/eLife.53447.
Cowell I, Ling E, Swan R, Brooks M, Austin C
Mol Pharmacol. 2019; 96(5):562-572.
PMID: 31515282
PMC: 6776009.
DOI: 10.1124/mol.119.117390.
Holden J
Endocr Pathol. 2016; 10(2):97-102.
PMID: 27519213
DOI: 10.1007/BF02739821.
Zhang H, Zhang Y, Yasukawa T, Dalla Rosa I, Khiati S, Pommier Y
Nucleic Acids Res. 2014; 42(11):7259-67.
PMID: 24803675
PMC: 4066791.
DOI: 10.1093/nar/gku384.
Mechanisms regulating resistance to inhibitors of topoisomerase II.
Ganapathi R, Ganapathi M
Front Pharmacol. 2013; 4:89.
PMID: 23914174
PMC: 3729981.
DOI: 10.3389/fphar.2013.00089.
Repair of DNA strand breaks in a minichromosome in vivo: kinetics, modeling, and effects of inhibitors.
Kumala S, Fujarewicz K, Jayaraju D, Rzeszowska-Wolny J, Hancock R
PLoS One. 2013; 8(1):e52966.
PMID: 23382828
PMC: 3559499.
DOI: 10.1371/journal.pone.0052966.
(-)-Xanthatin up-regulation of the GADD45γ tumor suppressor gene in MDA-MB-231 breast cancer cells: role of topoisomerase IIα inhibition and reactive oxygen species.
Takeda S, Noguchi M, Matsuo K, Yamaguchi Y, Kudo T, Nishimura H
Toxicology. 2013; 305:1-9.
PMID: 23313378
PMC: 4030303.
DOI: 10.1016/j.tox.2012.12.019.
Distribution of gyrase and topoisomerase IV on bacterial nucleoid: implications for nucleoid organization.
Hsu Y, Chung M, Li T
Nucleic Acids Res. 2006; 34(10):3128-38.
PMID: 16757578
PMC: 1475751.
DOI: 10.1093/nar/gkl392.
Clerocidin interacts with the cleavage complex of Streptococcus pneumoniae topoisomerase IV to induce selective irreversible DNA damage.
Richter S, Leo E, Giaretta G, Gatto B, Fisher L, Palumbo M
Nucleic Acids Res. 2006; 34(7):1982-91.
PMID: 16614448
PMC: 1435983.
DOI: 10.1093/nar/gkl127.
Genetic analysis of the requirements for SOS induction by nalidixic acid in Escherichia coli.
Newmark K, OReilly E, Pohlhaus J, Kreuzer K
Gene. 2005; 356:69-76.
PMID: 16005583
PMC: 2200294.
DOI: 10.1016/j.gene.2005.04.029.
Norfloxacin-induced DNA gyrase cleavage complexes block Escherichia coli replication forks, causing double-stranded breaks in vivo.
Pohlhaus J, Kreuzer K
Mol Microbiol. 2005; 56(6):1416-29.
PMID: 15916595
PMC: 1201555.
DOI: 10.1111/j.1365-2958.2005.04638.x.
True reversal of Mu integration.
Au T, Pathania S, Harshey R
EMBO J. 2004; 23(16):3408-20.
PMID: 15282550
PMC: 514517.
DOI: 10.1038/sj.emboj.7600344.
Endonuclease cleavage of blocked replication forks: An indirect pathway of DNA damage from antitumor drug-topoisomerase complexes.
Hong G, Kreuzer K
Proc Natl Acad Sci U S A. 2003; 100(9):5046-51.
PMID: 12704241
PMC: 154295.
DOI: 10.1073/pnas.0835166100.
Schedule-dependent response of neuroblastoma cell lines to combinations of etoposide and cisplatin.
Meczes E, Pearson A, Austin C, Tilby M
Br J Cancer. 2002; 86(3):485-9.
PMID: 11875719
PMC: 2375204.
DOI: 10.1038/sj.bjc.6600060.
Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia.
Zhang Y, Strissel P, Strick R, Chen J, Nucifora G, Le Beau M
Proc Natl Acad Sci U S A. 2002; 99(5):3070-5.
PMID: 11867721
PMC: 122474.
DOI: 10.1073/pnas.042702899.
Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia.
Strick R, Strissel P, Borgers S, Smith S, Rowley J
Proc Natl Acad Sci U S A. 2000; 97(9):4790-5.
PMID: 10758153
PMC: 18311.
DOI: 10.1073/pnas.070061297.
An antitumor drug-induced topoisomerase cleavage complex blocks a bacteriophage T4 replication fork in vivo.
Hong G, Kreuzer K
Mol Cell Biol. 1999; 20(2):594-603.
PMID: 10611238
PMC: 85141.
DOI: 10.1128/MCB.20.2.594-603.2000.
Activation of topoisomerase II-mediated excision of chromosomal DNA loops during oxidative stress.
Li T, Chen A, Yu C, Mao Y, Wang H, Liu L
Genes Dev. 1999; 13(12):1553-60.
PMID: 10385624
PMC: 316815.
DOI: 10.1101/gad.13.12.1553.
Attenuation of drug-stimulated topoisomerase II-DNA cleavable complex formation in wild-type HL-60 cells treated with an intracellular calcium buffer is correlated with decreased cytotoxicity and site-specific hypophosphorylation of topoisomerase....
Aoyama M, Grabowski D, Dubyak G, Constantinou A, Rybicki L, Bukowski R
Biochem J. 1998; 336 ( Pt 3):727-33.
PMID: 9841887
PMC: 1219926.
DOI: 10.1042/bj3360727.